¿Es lavandula angustifolia oil seguro durante el embarazo?
Case reports plus in vitro studies show Lavandula angustifolia (lavender) oil and major constituents (linalool, linalyl acetate and others) have estrogenic and anti‑androgenic activity; human case reports link repeated topical exposure to prepubertal breast development. No EU Annex II/III ban or harmonised CLP reproductive classification was found, but the demonstrated endocrine activity and human case evidence support a suspected reproductive/ endocrine hazard. (Sources: Henley NEJM 2007; J Clin Endocrinol Metab 2018; systematic reviews).
Pregnancy-safe products containing lavandula angustifolia oil










Alternativas seguras a lavandula angustifolia oil en el embarazo | VeriMom
Related ingredients
Frequently asked questions
- ¿Es lavandula angustifolia oil seguro durante el embarazo?
- Case reports plus in vitro studies show Lavandula angustifolia (lavender) oil and major constituents (linalool, linalyl acetate and others) have estrogenic and anti‑androgenic activity; human case reports link repeated topical exposure to prepubertal breast development. No EU Annex II/III ban or harmonised CLP reproductive classification was found, but the demonstrated endocrine activity and human case evidence support a suspected reproductive/ endocrine hazard. (Sources: Henley NEJM 2007; J Clin Endocrinol Metab 2018; systematic reviews).
- ¿Es lavandula angustifolia oil seguro durante la lactancia?
- Mechanistic evidence (in vitro estrogenic/anti‑androgenic activity) and human case reports raise concern for endocrine activity; topical maternal exposures are absorbable at low but measurable levels. There is no specific regulatory ban or harmonised classification that changes this view, but the endocrine activity supports a suspected hazard during lactation. Stopping exposure removes the effect in reported cases. (Sources: NEJM 2007; J Clin Endocrinol Metab 2018; reviews).
- ¿Es lavandula angustifolia oil seguro para la piel del bebé?
- Same mechanistic/human-case evidence applies. Because infant skin has higher absorption and surface‑area‑to‑weight, exposure score increased by +1. Case reports involved topical exposure in children with breast tissue changes that regressed after discontinuation; in vitro data show estrogenic/anti‑androgenic activity of lavender oil constituents. No infant‑specific harmonised classification or EU ban was identified. (Sources: NEJM 2007; J Clin Endocrinol Metab 2018; systematic reviews; Archives of Toxicology 2023).
- ¿Cómo puntúa VeriMom a lavandula angustifolia oil?
- VeriMom puntúa lavandula angustifolia oil en 40/100 (riesgo medio) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a lavandula angustifolia oil en el embarazo?
- Consulta nuestra lista de alternativas seguras a lavandula angustifolia oil según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.